Therapeutic Efficacy of a Herpes Simplex Virus With Radiation or Temozolomide for Intracranial Glioblastoma After Convection-enhanced Delivery
Open Access
- 1 November 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (11) , 1783-1788
- https://doi.org/10.1038/mt.2008.185
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0Journal of Virology, 2006
- ICP0 Gene Expression Is a Herpes Simplex Virus Type 1 Apoptotic TriggerJournal of Virology, 2006
- Reciprocal Activities between Herpes Simplex Virus Type 1 Regulatory Protein ICP0, a Ubiquitin E3 Ligase, and Ubiquitin-Specific Protease USP7Journal of Virology, 2005
- Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma MultiformeClinical Cancer Research, 2005
- Inhibition of DNA Repair by a Herpes Simplex Virus Vector Enhances the Radiosensitivity of Human Glioblastoma CellsCancer Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracerJournal of Neurosurgery, 2005
- Degradation of Nucleosome-associated Centromeric Histone H3-like Protein CENP-A Induced by Herpes Simplex Virus Type 1 Protein ICP0Journal of Biological Chemistry, 2001
- Effective Treatment of Experimental Glioblastoma by HSV Vector-Mediated TNFα and HSV-tk Gene Transfer in Combination with Radiosurgery and Ganciclovir AdministrationMolecular Therapy, 2000
- Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumorsGene Therapy, 1998